[Surgical therapy of bronchial carcinoma].
Chest surgery is a fundamental component of the interdisciplinary diagnostic and therapeutic procedures for lung cancer. NSCLC is usually treated by surgical resection. The long-term prognosis after chest surgery decidedly depends on the tumour stage. Integration of surgery into a combined therapeutic concept (multimodal, adjuvant or neoadjuvant) improves the therapeutic outcome of advanced cases.
Skuballa
Axel
A
Klinik für Thoraxchirurgie, Thoraxzentrum des Klinikums St. Georg gGmbH, Leipzig. Axel.Skuballa@sanktgeorg.de
D002289:Carcinoma, Non-Small-Cell Lung / Q000601:surgery*; D018288:Carcinoma, Small Cell / Q000601:surgery*; D003131:Combined Modality Therapy; D006801:Humans; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D008197:Lymph Node Excision; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D010178:Pancoast Syndrome / Q000601:surgery; D011013:Pneumonectomy; D011379:Prognosis; D020775:Thoracic Surgery, Video-Assisted; D013997:Time Factors; D016896:Treatment Outcome